Related Experiment Video
Updated: Jun 29, 2025
Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
Published on: July 17, 2012
Label-free optical imaging for brain cancer assessment
Raksha Raghunathan1, Matthew Vasquez1, Katherine Zhang1
1Department of Systems Medicine and Bioengineering and T.T. and W.F. Chao Center for BRAIN, Houston Methodist Neal Cancer Center, Houston Methodist Hospital, Houston, TX 77030, USA; Advanced Cellular and Tissue Microscopy Core, Houston Methodist Neal Cancer Center and Houston Methodist Research Institute, Houston, TX 77030, USA.
Label-free optical imaging provides high-resolution, real-time brain cancer assessment without radiation. Techniques like photoacoustic imaging (PAI) and optical coherence tomography (OCT) improve early detection and treatment strategies.
Area of Science:
- Medical Imaging
- Oncology
- Biophotonics
Background:
- Traditional brain cancer imaging (MRI, CT, PET) has limitations.
- Label-free optical imaging offers advanced, non-invasive alternatives.
- These methods provide high-resolution, real-time insights without radiation or contrast agents.
Purpose of the Study:
- To review advances in label-free optical imaging for brain cancer.
- To highlight the role of these techniques in detection, diagnosis, and management.
- To underscore their importance in improving early detection and therapeutic strategies.
Main Methods:
- Photoacoustic Imaging (PAI)
- Optical Coherence Tomography (OCT)
- Raman Imaging
- Infrared (IR) Microscopy
Main Results:
- Label-free optical methods offer superior resolution compared to MRI, CT, and PET.
- These techniques provide cost-effective and accessible imaging options.
- Recent advances enhance the capabilities for brain tumor assessment.
Conclusions:
- Label-free optical imaging is a promising approach for brain cancer assessment.
- These advanced techniques are crucial for enhancing early detection.
- Further development will refine therapeutic strategies for brain tumors.
